| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |